RAPT Therapeutics Inc. Overview

RAPT Therapeutics, Inc., a pharmaceutical company based in South San Francisco, United States, operates globally in the health care sector. The company specializes in immunology, small molecule drug discovery, and computational biology services, focusing on combating cancer and allergic inflammatory diseases. RAPT Therapeutics is listed on the Nasdaq stock exchange and trades under the currency of USD.

Recent Financial Performance

As of June 3, 2025, RAPT Therapeutics closed at a price of $1.02 per share. The company’s stock has experienced significant fluctuations over the past year. The 52-week high was recorded at $4.01 on June 6, 2024, while the 52-week low was $0.708 on May 14, 2025. The market capitalization of RAPT Therapeutics stands at approximately $124,100,030 USD.

Company Focus and Services

RAPT Therapeutics is dedicated to advancing treatments for cancer and allergic inflammatory diseases through its specialized services. The company leverages its expertise in immunology, small molecule drug discovery, and computational biology to develop innovative solutions in the pharmaceutical industry. For more detailed information about their offerings and initiatives, interested parties can visit their website at www.rapt.com .

Conclusion

RAPT Therapeutics, Inc. continues to play a significant role in the health care sector with its focus on critical areas of drug discovery and development. Despite recent stock price volatility, the company remains committed to its mission of addressing complex health challenges through cutting-edge scientific approaches.